Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
20. November 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16920
Articles 1 - 20 / 338392
Handheld Raman spectroscopy for ex vivo molecular assessment of cervical lesions: A methodological feasibility study.
PLoS One
Zhang Y, Wang H, He Y, Zhang S, Wang P, Han Y.
PMID: 43056359 [PubMed - indexed for MEDLINE]
The Silent Struggle: A Hermeneutic Phenomenological Study of Men's Lived Experiences of Breast Cancer.
Cancer Control
Nwozichi C, Dartois A, Hile A, Uhuangho O, Salako O.
PMID: 43056225 [PubMed - indexed for MEDLINE]
Vulvar Paget Disease: From Empirical Management to Emerging Precision Oncology Strategies.
Curr Oncol Rep
Corrado G, Pomati G, Palluzzi E, Manna G, Fragomeni SM, Federico A, Vizzielli G, Perrone AM, Lanzetta G, Fagotti A, Garganese G.
PMID: 43056017 [PubMed - indexed for MEDLINE]
Added effects of manual lymphatic drainage and intermittent pneumatic compression on compression-based care for established upper-limb breast-cancer-related lymphedema: a systematic review and component network meta-analysis.
Support Care Cancer
Low JJY, Kuo HW, Kuppusamy VA, Ong CSN, Tan BZL, Lim EX, Tan SXB, Kota VG, Leo HL.
PMID: 43055979 [PubMed - indexed for MEDLINE]
Mitochondrial DNA methylation in breast cancer: biological insights, biomarker potential, and methodological challenges.
Mol Biol Rep
Cotino-Nájera S, Muñoz-Gómez R, Muñoz ML.
PMID: 43055879 [PubMed - indexed for MEDLINE]
Adjuvant chemotherapy and overall survival in premenopausal women with HR+/HER2 - early breast cancer: a national cancer database analysis in the era of genomic testing and CDK4/6 inhibitors.
Breast Cancer Res Treat
Lopetegui-Lia N, Gokun Y, Davenport AP, Roy AM, Burke E, Andraos TY, Agnese DM, LeFebvre HM, Slover B, Gatti-Mays M, Johnson KCC, Stover DG, Myers SP.
PMID: 43055841 [PubMed - indexed for MEDLINE]
Mechanism-based targeted drug delivery strategies for uterine fibroids (leiomyomas): from pathogenesis to therapy.
Mol Biol Rep
Firdous Z, Shirasath KR, Goyal SN, Agrawal YO.
PMID: 43055840 [PubMed - indexed for MEDLINE]
Germline genetic testing for patients with stage IV breast cancer: a qualitative study from the patient's perspective.
Med Oncol
de Jong CL, van der Giessen JAM, Bijlsma RM, van de Beek I, Haadsma ML, Schijven G, Engelhardt EG, Jager A, Ausems MGEM.
PMID: 43055831 [PubMed - indexed for MEDLINE]
Biomarker guided therapy in triple-negative breast cancer: Clinical role of ctDNA and PD-L1.
J Oncol Pharm Pract
Boregowda SS, Chowdappa G, Jayaramu RA, Divyasree BG, Bhoomika B, Rajesh S, Jeeva Jothi B.
PMID: 43055307 [PubMed - as supplied by publisher]
Occult Malignancy and Atypical Proliferative Lesions in Reduction Mammaplasty Specimens Without History of Breast Cancer: Systematic Review and Meta-Analysis.
Aesthet Surg J
Skorochod R, Gronovich Y.
PMID: 43055120 [PubMed - as supplied by publisher]
Early Detection of Ovarian Cancer: Current Strategies and Future Directions.
Expert Rev Mol Med
Zhang N, Zhuang D, Wang Y, Guo C, Gao Y, Feng Y, Wu H, Zhang Y, Hu G.
PMID: 43055119 [PubMed - indexed for MEDLINE]
Immunohistochemical Insights on Mismatch Repair Proteins in Ovarian Carcinoma: A North Indian Cohort Study.
J Midlife Health
Chawhan P, Sharma S, Singh M.
PMID: 43054996 [PubMed]
Cancer Risk in Premature Ovarian Insufficiency: Current Evidence and Clinical Implications.
J Midlife Health
Devanbu VGC, John JB, Karpagam KV.
PMID: 43054964 [PubMed]
Familial germ cell tumors: A case of ovarian yolk sac tumor in a patient with Lynch syndrome and two brothers diagnosed with testicular seminomas.
Gynecol Oncol Rep
Crockett SA, Singleton M, O'Daniel J, Ferrick JP, Clark LH.
PMID: 43054867 [PubMed]
AI-driven Immuno-Radio-Multi-Omics in triple-negative breast cancer: mapping the immune landscape for precision immunotherapy.
Front Immunol
Haloum I, Badou A.
PMID: 43054707 [PubMed - indexed for MEDLINE]
Development, Comparison With Genetic Counselors' Assessments, and Usability Evaluation of Japanese Version of Cancer Risk Assessment System in Primary Care (JCRAS-PC) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
J Gen Fam Med
Narumoto K, Kojima R, Shibata A, Miyazaki K, Koizumi K, Osawa H, Kato S, Iwaizumi M.
PMID: 43054666 [PubMed]
Multimodal versus Conventional Opioid-Based Analgesia and Postoperative Outcomes After Breast Cancer Surgery: A Retrospective Cohort Study.
J Pain Res
Guo H, Liu X, Meng Y, Li M, Niu Y.
PMID: 43054601 [PubMed]
MicroRNA-mediated crosstalk between Wnt/β-catenin signaling and the NLRP3 inflammasome in breast cancer: mechanistic evidence and therapeutic implications.
Front Oncol
Bharti M, Mishra S, Khanna S, Kailashiya J, Mishra SP.
PMID: 43054551 [PubMed]
Reciprocal Risk of Cutaneous Melanoma and Female Breast Carcinoma: A Queensland Population Study, 1995-2022.
Int J Breast Cancer
Jeyakumar A, Ng SK, Lam AK, Gopalan V.
PMID: 43054545 [PubMed]
Rewiring the breast cancer immune microenvironment through non-coding RNA-macrophage crosstalk: therapeutic vulnerabilities for immune reprogramming.
Front Immunol
Kumar S, Sharma P, Nema RK, Sisodiya S, Pramanik R, Hussain S, Singh S.
PMID: 43054268 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 338392
Page 1 of 16920
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy